Lipocine Inc.LPCNNASDAQ
Loading
LPCN Revenue Growth (YoY Quarterly)•-67.19%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
-67.19%
-67.2pp
-67.62%
-67.6pp
-260.33%
-260.3pp
-262.78%
-262.8pp
-232.99%
-233.0pp
-227.27%
-227.3pp
-231.25%
-231.3pp
+2.06%
+0.8pp
+5.27%
+4.0pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +1514.99% | -98.77% | +595.42% | +0.00% | -67.19% |
| Gross Profit Growth | +1514.99% | -98.77% | +0.00% | +0.00% | -67.62% |
| EBITDA Growth | +0.00% | -164.21% | +0.00% | +0.00% | -260.33% |
| Operating Income Growth | +0.00% | -164.86% | +0.00% | +0.00% | -262.78% |
| Net Income Growth | +0.00% | -153.08% | +0.00% | +0.00% | -232.99% |
| EPS Growth | +0.00% | -153.03% | +0.00% | +0.00% | -227.27% |
| EPS Diluted Growth | +0.00% | -153.03% | +0.00% | +0.00% | -231.25% |
| Weighted Average Shares Growth | +0.97% | +0.62% | +0.15% | +1.22% | +2.06% |
| Weighted Average Shares Diluted Growth | +2.00% | -0.17% | +0.15% | +1.22% | +5.27% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -181.80% | +0.00% | +0.00% | -271.54% |
| Free Cash Flow Growth | +0.00% | -181.80% | +0.00% | +0.00% | -272.56% |
| Receivables Growth | +130.50% | +78.79% | +91.29% | +26.01% | -88.22% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -2.13% | -19.44% | -19.34% | -22.35% | -24.45% |
| Book Value per Share Growth | +2.09% | -20.34% | -19.36% | -26.92% | -32.44% |
| Debt Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| R&D Expense Growth | +0.00% | -62.34% | +0.00% | +70.81% | +151.09% |
| SG&A Expenses Growth | -23.05% | -28.76% | -40.93% | -26.54% | +12.64% |
1 / 4